We are live on ! Find out more
AKBA icon

Akebia Therapeutics
AKBA

75 hedge funds and large institutions have $30.9M invested in Akebia Therapeutics in 2022 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 7 increasing their positions, 32 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

926% more call options, than puts

Call options by funds: $400K | Put options by funds: $39K

87% more capital invested

Capital invested by funds: $16.5M → $30.9M (+$14.4M)

0.03% more ownership

Funds ownership: 28.39% → 28.41% (+0.03%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

17% less funds holding

Funds holding: 90 → 75 (-15)

61% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 23

78% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 32

Holders
75
Holders Change
-15
Holders Change %
-16.67%
% of All Funds
1.21%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
9
Increased
7
Reduced
32
Closed
23
Calls
$400K
Puts
$39K
Net Calls
+$361K
Net Calls Change
+$116K

Top Buyers

Rank Fund Capital Flow
1
AIM
Alerce Investment Management
Illinois
+$3.27M
2
Jane Street
Jane Street
New York
+$161K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$20.2K
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$19K
5
TSS
Two Sigma Securities
New York
+$18.1K

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$670K
2
Vanguard Group
Vanguard Group
Pennsylvania
-$609K
3
BlackRock
BlackRock
New York
-$428K
4
Federated Hermes
Federated Hermes
Pennsylvania
-$245K
5
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$199K
Name Holding Trade Value Shares
Change 		Change in
Stake
CSS
51
Cubist Systematic Strategies
Connecticut
$6.48K +$3.52K +11,232 New
SIMG
52
Sonora Investment Management Group
Arizona
$6.4K – – –
UCFA
53
United Capital Financial Advisors
Texas
$5.97K – – –
BNP Paribas Financial Markets
54
BNP Paribas Financial Markets
France
$5.5K -$4.79K -15,286 -62%
AF
55
Advisornet Financial
Minnesota
$2.88K – – –
JP Morgan Chase
56
JP Morgan Chase
New York
$2K -$2.3K -7,347 -64%
Rockefeller Capital Management
57
Rockefeller Capital Management
New York
$2K – – –
Fifth Third Bancorp
58
Fifth Third Bancorp
Ohio
$1.9K – – –
BAM
59
Belpointe Asset Management
Nevada
$1.29K +$703 +2,243 New
TWC
60
TD Waterhouse Canada
Ontario, Canada
$1.26K – – –
USCWA
61
U.S. Capital Wealth Advisors
Texas
$1.08K +$586 +1,871 New
EWA
62
EverSource Wealth Advisors
Alabama
$721 – – –
TC
63
Truvestments Capital
Florida
$436 – – –
AF
64
Allworth Financial
California
$432 +$234 +748 New
Citigroup
65
Citigroup
New York
$419 -$14.4K -45,897 -98%
BWP
66
Baldwin Wealth Partners
Massachusetts
$324 – – –
Northwestern Mutual Wealth Management
67
Northwestern Mutual Wealth Management
Wisconsin
$216 +$117 +374 New
HCP
68
Hexagon Capital Partners
Arkansas
$107 – – –
FDCDDQ
69
Federation des caisses Desjardins du Quebec
Quebec, Canada
$87 – – –
Belvedere Trading
70
Belvedere Trading
Illinois
$58 +$31 +100 New
FWM
71
Focused Wealth Management
New York
$38 – – –
CS
72
Credit Suisse
Switzerland
$3 – – –
NA
73
NewEdge Advisors
Louisiana
$2 +$1.04K +3,335 New
Dimensional Fund Advisors
74
Dimensional Fund Advisors
Texas
– -$199K -627,549 Closed
GCP
75
GSA Capital Partners
United Kingdom
– -$154K -486,568 Closed
1 2
3
4

AKBA Hedge Fund Activity: Q4 2022 in Review

75 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Akebia Therapeutics (AKBA) for Q4 2022, worth a combined $30.9M — up 87% from $16.5M a quarter earlier.

Sellers outnumbered buyers: 23 funds closed out of AKBA and 9 opened new positions — a net loss of 14 holders — while 32 trimmed existing stakes and 7 added.

The largest buyer was Alerce Investment Management, adding an estimated $3.27M. The largest seller was Millennium Management, cutting an estimated $670K.

  • 75 institutional investors held Akebia Therapeutics (AKBA) as of Q4 2022, down from 90 in Q3 2022.
  • Funds reported $30.9M of Akebia Therapeutics stock for Q4 2022, up 87% quarter-over-quarter.
  • 9 funds opened new Akebia Therapeutics positions in Q4 2022 and 23 closed out, a net change of -14 holders.
  • The largest Akebia Therapeutics buyer in Q4 2022 was Alerce Investment Management, an estimated $3.27M added.
  • The largest Akebia Therapeutics seller in Q4 2022 was Millennium Management, an estimated $670K sold.

Based on aggregated 13F filings for Q4 2022.